ROME Therapeutics

Biotechnology company focused on exploring the 'dark genome' to develop new treatments for serious diseases. ROME Therapeutics differentiates itself by bringing together a multidisciplinary team of experts in oncology, immunology, machine learning, virology, and theoretical physics, and collaborating with top academic labs in cutting-edge research areas. The company's work primarily benefits patients suffering from serious diseases who may benefit from novel therapeutic approaches.